CIM
THC icon

Cambria Investment Management’s Tenet Healthcare THC Stock Holding History

Cambria Investment Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Buy
53,590
+6,413
+14% +$1.18M 0.5% 43
2026
Q1 		$8.9M Buy
47,177
+1,004
+2% +$212K 0.5% 117
2025
Q4 		$9.18M Sell
46,173
-27,710
-38% -$5.6M 0.54% 34
2025
Q3 		$15M Sell
73,883
-4,956
-6% -$879K 0.91% 7
2025
Q2 		$13.9M Sell
78,839
-11,159
-12% -$1.68M 0.93% 10
2025
Q1 		$12.1M Sell
89,998
-9,286
-9% -$1.22M 0.84% 28
2024
Q4 		$12.5M Buy
99,284
+95,965
+2,891% +$14.3M 0.76% 46
2024
Q3 		$552K Buy
3,319
+585
+21% +$88.5K 0.03% 172
2024
Q2 		$364K Buy
+2,734
New +$329K 0.02% 263
2015
Q4 		– Sell
-408
Closed -$15K – 260
2015
Q3 		$15K Hold
408
– – 0.01% 245
2015
Q2 		$24K Buy
408
+335
+459% +$17.1K 0.01% 191
2015
Q1 		$4K Hold
73
– – ﹤0.01% 200
2014
Q4 		$4K Buy
+73
New +$3.82K ﹤0.01% 193

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cambria Investment Management's THC Position: Q2 2026 in Review

Cambria Investment Management increased its Tenet Healthcare (THC) stake by 14% in Q2 2026, buying an estimated $1.18M and bringing the position to 53,590 shares worth $10M. The position accounts for 0.5% of the portfolio, ranked #43.

Cambria Investment Management first reported a position in THC in Q4 2014 and has held it in 13 quarters since. The position peaked at $15M in Q3 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Cambria Investment Management held 53,590 shares of Tenet Healthcare worth $10M as of Q2 2026.
  • Cambria Investment Management bought 6,413 Tenet Healthcare shares in Q2 2026, an estimated $1.18M.
  • Tenet Healthcare made up 0.5% of Cambria Investment Management's portfolio in Q2 2026, its #43 holding.
  • Cambria Investment Management first reported a position in Tenet Healthcare in Q4 2014 and has held it in 13 quarters since.
  • Cambria Investment Management's Tenet Healthcare position peaked at $15M in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.